S. C. Linn

634 total citations
13 papers, 522 citations indexed

About

S. C. Linn is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, S. C. Linn has authored 13 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in S. C. Linn's work include Drug Transport and Resistance Mechanisms (7 papers), Cancer therapeutics and mechanisms (4 papers) and Pancreatic and Hepatic Oncology Research (2 papers). S. C. Linn is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Cancer therapeutics and mechanisms (4 papers) and Pancreatic and Hepatic Oncology Research (2 papers). S. C. Linn collaborates with scholars based in Netherlands, United States and France. S. C. Linn's co-authors include Giuseppe Giaccone, HM Pinedo, A.H. Honkoop, Klaas Hoekman, John Wagstaff, Herbert M. Pinedo, Paul van der Valk, C.K. van Kalken, Paul van der Valk and J. P. A. Baak and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

S. C. Linn

13 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. C. Linn Netherlands	10	311	182	147	110	74	13	522
RJ Scheper Netherlands	10	322 1.0×	281 1.5×	45 0.3×	56 0.5×	45 0.6×	16	557
Steven W. Remmenga United States	13	157 0.5×	347 1.9×	83 0.6×	73 0.7×	39 0.5×	20	720
Imane El Dika United States	13	214 0.7×	207 1.1×	145 1.0×	81 0.7×	18 0.2×	30	573
Astrid Mayer United Kingdom	8	367 1.2×	179 1.0×	53 0.4×	67 0.6×	109 1.5×	14	557
M Namer France	12	271 0.9×	94 0.5×	84 0.6×	55 0.5×	18 0.2×	36	442
Xiu Feng Hu Australia	14	310 1.0×	406 2.2×	75 0.5×	29 0.3×	35 0.5×	24	621
Evelien W. Duiker Netherlands	14	345 1.1×	332 1.8×	114 0.8×	32 0.3×	25 0.3×	26	750
Shinji Arao Japan	10	188 0.6×	282 1.5×	67 0.5×	63 0.6×	10 0.1×	12	427
Gayathri Anandappa United Kingdom	8	392 1.3×	183 1.0×	101 0.7×	38 0.3×	45 0.6×	18	698
Paul H. Fischer United States	12	259 0.8×	289 1.6×	70 0.5×	22 0.2×	58 0.8×	26	540

Countries citing papers authored by S. C. Linn

Since Specialization

Citations

This map shows the geographic impact of S. C. Linn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. C. Linn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. C. Linn more than expected).

Fields of papers citing papers by S. C. Linn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. C. Linn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. C. Linn. The network helps show where S. C. Linn may publish in the future.

Co-authorship network of co-authors of S. C. Linn

This figure shows the co-authorship network connecting the top 25 collaborators of S. C. Linn. A scholar is included among the top collaborators of S. C. Linn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. C. Linn. S. C. Linn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Siesling, Sabine, et al.. (2024). 236MO Pathologic complete response and survival after neoadjuvant chemotherapy in stage I TNBC: A registry-based study. Annals of Oncology. 35. S311–S311. 1 indexed citations

Linn, S. C., Esther H. Lips, Petra M. Nederlof, et al.. (2011). Genomic patterns resembling BRCA-mutated breast cancers and benefit of intensified carboplatin-based chemotherapy in HER2-negative breast cancer.. Journal of Clinical Oncology. 29(15_suppl). 10505–10505. 1 indexed citations

Honkoop, A.H., S. C. Linn, Giuseppe Giaccone, et al.. (1998). Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer. British Journal of Cancer. 77(4). 621–626. 144 indexed citations

Daggett, C.William, Mark Yeatman, Andrew J. Lodge, et al.. (1998). Total respiratory support from swine lungs in primate recipients. Journal of Thoracic and Cardiovascular Surgery. 115(1). 19–27. 59 indexed citations

Linn, S. C., A.H. Honkoop, Klaas Hoekman, et al.. (1996). p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer. British Journal of Cancer. 74(1). 63–68. 91 indexed citations

Linn, S. C. & Giuseppe Giaccone. (1995). MDR1/P-glycoprotein expression in colorectal cancer. European Journal of Cancer. 31(7-8). 1291–1294. 60 indexed citations

Linn, S. C., Giuseppe Giaccone, P. J. van Diest, et al.. (1995). Prognostic relevance of P-glycoprotein expression in breast cancer. Annals of Oncology. 6(7). 679–685. 73 indexed citations

Giaccone, Giuseppe, S. C. Linn, & Herbert M. Pinedo. (1995). Multidrug resistance in breast cancer: Mechanisms, strategies. European Journal of Cancer. 31. S15–S17. 15 indexed citations

Livant, Donna L., S. C. Linn, Sonja M. Markwart, & J J Shuster. (1995). Invasion of selectively permeable sea urchin embryo basement membranes by metastatic tumor cells, but not by their normal counterparts.. PubMed. 55(21). 5085–93. 26 indexed citations

10.

Broxterman, Henricus J., C. H. M. Versantvoort, & S. C. Linn. (1994). Multidrug resistance in lung cancer. Cancer treatment and research. 72. 193–222. 10 indexed citations

11.

Linn, S. C., C.K. van Kalken, Olaf van Tellingen, et al.. (1994). Clinical and pharmacologic study of multidrug resistance reversal with vinblastine and bepridil.. Journal of Clinical Oncology. 12(4). 812–819. 32 indexed citations

12.

Giaccone, Giuseppe, S. C. Linn, G. Catimel, et al.. (1994). SDZ PSC 833 in combination with doxorubicin. Anti-Cancer Drugs. 5. 42–42. 9 indexed citations

13.

Linn, S. C., J van Ark-Otte, Catharina M. Kuiper, et al.. (1994). Expression of multidrug resistance (MDR) genes in normal breast tissue, primary and advanced breast cancer and treatment outcome. Anti-Cancer Drugs. 5. 56–56. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact